Ketorolac API is a pharmaceutical-grade Non-Steroidal Anti-Inflammatory Drug (NSAID) indicated for the short-term management of moderate to severe acute pain. It provides potent analgesic, anti-inflammatory, and antipyretic effects by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing prostaglandin synthesis.
Ketorolac is widely used in injectable, oral, ophthalmic, and nasal spray formulations. It is commonly prescribed for postoperative pain, musculoskeletal pain, renal colic, and ocular inflammation following cataract or refractive surgery. Due to the increased risk of gastrointestinal and renal adverse effects, treatment duration is generally limited to short-term use.
Manufactured under WHO-GMP-certified facilities, our Ketorolac API is produced using advanced pharmaceutical manufacturing technologies to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes comprehensive analytical testing and is supplied with complete documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Ketorolac API is used in pharmaceutical formulations for the short-term treatment of moderate to severe acute pain, postoperative pain, and ocular inflammation.
Ketorolac inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin production responsible for pain, inflammation, and fever.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Ketorolac API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp